Condition: Diabetes Mellitus, Type 2 · Obesity · Sponsor: University Hospital, Grenoble
The primary objective of this study is to assess the efficacy of endoscopic gastric reduction with the endomina® device, in combination with standard of care, compared to standard of care alone, on the remission of diabetes 24 months after surgery, in patients with type-2 diabetes and class I obesity.
This description comes directly from the study's public registry record.
L. LECLERCQ, MSc · +3271919409 · ESTIME@endotools.be
Always discuss trial participation with your own doctor first.
| Chu Grenoble Alpes | La Tronche, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05516576